• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Tuesday 12/18/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Flonase

  • 7:33 AM

    May 09, 2017, INNV OTC Disclosure & News Service – Innovus Pharmaceuticals, Inc. (the “Company” or “Innovus Pharma”) (OTCQB Venture Market: INNV) and its partner West-Ward Pharmaceuticals International Limited (“WWPIL”), a wholly-owned subsidiary of Hikma Pharmaceuticals PLC (“Hikma”) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), today announced that WWPIL will provide the Company with the rights to launch its branded, fluticasone propionate nasal spray USP, 50 mcg per spray (FlutiCare™), under WWPIL’s FDA approved abbreviated new drug application (“ANDA”) No.

    Read more
  • 4:04 AM

    TORONTO, Apr 10, 2014 (Canada NewsWire via COMTEX) — SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has closed its previously announced public offering (the “Offering”). Pursuant to the Offering, SQI issued 8,400,000 units of the Company (“Units”) at a price of C$0.50 per Unit for gross proceeds of C$4.2 million. Each Unit is comprised of one

    Read more
Public Wire Banner